1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–32. 2016. View Article : Google Scholar : PubMed/NCBI
|
4
|
Benitez Majano S, Di Girolamo C, Rachet B,
Maringe C, Guren MG, Glimelius B, Iversen LH, Schnell EA, Lundqvist
K, Christensen J, et al: Surgical treatment and survival from
colorectal cancer in Denmark, England, Norway, and Sweden: A
population-based study. Lancet Oncol. 20:74–87. 2019. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bass AJ, Lawrence MS, Brace LE, Ramos AH,
Drier Y, Cibulskis K, Sougnez C, Voet D, Saksena G, Sivachenko A,
et al: Genomic sequencing of colorectal adenocarcinomas identifies
a recurrent VTI1A-TCF7L2 fusion. Nat Genet. 43:964–968. 2011.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Sjöblom T, Jones S, Wood LD, Parsons DW,
Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, et al:
The consensus coding sequences of human breast and colorectal
cancers. Science. 314:268–274. 2006. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wood LD, Parsons DW, Jones S, Lin J,
Sjöblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al: The
genomic landscapes of human breast and colorectal cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
9
|
Cancer Genome Atlas Network: Comprehensive
molecular characterization of human colon and rectal cancer.
Nature. 487:330–337. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Bronner IF, Quail MA, Turner DJ and
Swerdlow H: Improved protocols for Illumina sequencing. Curr Protoc
Hum Genet. 80:18.2.1–42. 2014. View Article : Google Scholar
|
11
|
Wei X, Sun Y, Xie J, Shi Q, Qu N, Yang G,
Cai J, Yang Y, Liang Y, Wang W and Yi X: Next-generation sequencing
identifies a novel compound heterozygous mutation in MYO7A in a
Chinese patient with Usher Syndrome 1B. Clin Chim Acta.
413:1866–1871. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Shao D, Lin Y, Liu J, Wan L, Liu Z, Cheng
S, Fei L, Deng R, Wang J, Chen X, et al: A targeted next-generation
sequencing method for identifying clinically relevant mutation
profiles in lung adenocarcinoma. Sci Rep. 6:223382016. View Article : Google Scholar : PubMed/NCBI
|
13
|
Li H and Durbin R: Fast and accurate short
read alignment with Burrows-Wheeler transform. Bioinformatics.
25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
McKenna A, Hanna M, Banks E, Sivachenko A,
Cibulskis K, Kernytsky A, Garimella K, Altshuler D, Gabriel S, Daly
M and DePristo MA: The genome analysis toolkit: A MapReduce
framework for analyzing next-generation DNA sequencing data. Genome
Res. 20:1297–1303. 2010. View Article : Google Scholar : PubMed/NCBI
|
15
|
Gibbs RA, Boerwinkle E, Doddapaneni H, Zhu
H, Alkan C, Dal E, Kahveci F, Garrison EP, Kural D, Lee WP and
Dermitzakis ET: A global reference for human genetic variation.
Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
|
16
|
Sherry ST, Ward MH, Kholodov M, Baker J,
Phan L, Smigielski EM and Sirotkin K: dbSNP: The NCBI database of
genetic variation. Nucleic Acids Res. 29:308–311. 2001. View Article : Google Scholar : PubMed/NCBI
|
17
|
Cingolani P, Platts A, Wang le L, Coon M,
Nguyen T, Wang L, Land SJ, Lu X and Ruden DM: A program for
annotating and predicting the effects of single nucleotide
polymorphisms, SnpEff: SNPs in the genome of Drosophila
melanogaster strain w1118; iso-2; iso-3. Fly (Austin). 6:80–92.
2012. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lawrence MS, Stojanov P, Polak P, Kryukov
GV, Cibulskis K, Sivachenko A, Carter SL, Stewart C, Mermel CH,
Roberts SA, et al: Mutational heterogeneity in cancer and the
search for new cancer-associated genes. Nature. 499:214–218. 2013.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Gonzalez-Perez A and Lopez-Bigas N:
Functional impact bias reveals cancer drivers. Nucleic Acids Res.
40:e1692012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Dong C, Guo Y, Yang H, He Z, Liu X and
Wang K: iCAGES: Integrated CAncer GEnome Score for comprehensively
prioritizing driver genes in personal cancer genomes. Genome Med.
8:1352016. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tokheim CJ, Papadopoulos N, Kinzler KW,
Vogelstein B and Karchin R: Evaluating the evaluation of cancer
driver genes. Proc Natl Acad Sci USA. 113:14330–14335. 2016.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhao X, Lei Y, Li G, Cheng Y, Yang H, Xie
L, Long H and Jiang R: Integrative analysis of cancer driver genes
in prostate adenocarcinoma. Mol Med Rep. 19:2707–2715.
2019.PubMed/NCBI
|
23
|
Huang da W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar : PubMed/NCBI
|
24
|
Kanehisa M, Furumichi M, Tanabe M, Sato Y
and Morishima K: KEGG: New perspectives on genomes, pathways,
diseases and drugs. Nucleic Acids Res. 45(D1): D353–D361. 2017.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Li J, Lupat R, Amarasinghe KC, Thompson
ER, Doyle MA, Ryland GL, Tothill RW, Halgamuge SK, Campbell IG and
Gorringe KL: CONTRA: Copy number analysis for targeted
resequencing. Bioinformatics. 28:1307–1313. 2012. View Article : Google Scholar : PubMed/NCBI
|
26
|
Greenman C, Stephens P, Smith R, Dalgliesh
GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C,
et al: Patterns of somatic mutation in human cancer genomes.
Nature. 446:153–158. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Barbieri CE, Baca SC, Lawrence MS,
Demichelis F, Blattner M, Theurillat JP, White TA, Stojanov P, Van
Allen E, Stransky N, et al: Exome sequencing identifies recurrent
SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat Genet.
44:685–689. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Grasso CS, Wu YM, Robinson DR, Cao X,
Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC,
et al: The mutational landscape of lethal castration-resistant
prostate cancer. Nature. 487:239–243. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Collisson EA, Campbell JD, Brooks AN,
Berger AH, Lee W, Chmielecki J, Beer DG, Cope L, Creighton CJ,
Danilova L, et al: Comprehensive molecular profiling of lung
adenocarcinoma. Nature. 511:543–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
30
|
Sato Y, Yoshizato T, Shiraishi Y, Maekawa
S, Okuno Y, Kamura T, Shimamura T, Sato-Otsubo A, Nagae G, Suzuki
H, et al: Integrated molecular analysis of clear-cell renal cell
carcinoma. Nat Genet. 45:860–867. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Cancer Genome Atlas Research Network, .
Integrated genomic characterization of papillary thyroid carcinoma.
Cell. 159:676–690. 2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Dees ND, Zhang Q, Kandoth C, Wendl MC,
Schierding W, Koboldt DC, Mooney TB, Callaway MB, Dooling D, Mardis
ER, et al: MuSiC: Identifying mutational significance in cancer
genomes. Genome Res. 22:1589–1598. 2012. View Article : Google Scholar : PubMed/NCBI
|
33
|
Sim NL, Kumar P, Hu J, Henikoff S,
Schneider G and Ng PC: SIFT web server: Predicting effects of amino
acid substitutions on proteins. Nucleic Acids Res. 40((Web Server
Issue)): W452–W457. 2012. View Article : Google Scholar : PubMed/NCBI
|
34
|
Adzhubei IA, Schmidt S, Peshkin L,
Ramensky VE, Gerasimova A, Bork P, Kondrashov AS and Sunyaev SR: A
method and server for predicting damaging missense mutations. Nat
Methods. 7:248–249. 2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Reva B, Antipin Y and Sander C: Predicting
the functional impact of protein mutations: Application to cancer
genomics. Nucleic Acids Res. 39:e1182011. View Article : Google Scholar : PubMed/NCBI
|
36
|
González-Pérez A and López-Bigas N:
Improving the assessment of the outcome of nonsynonymous SNVs with
a consensus deleteriousness score, Condel. Am J Hum Genet.
88:440–449. 2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Giannakis M, Mu XJ, Shukla SA, Qian ZR,
Cohen O, Nishihara R, Bahl S, Cao Y, Amin-Mansour A, Yamauchi M, et
al: Genomic correlates of immune-cell infiltrates in colorectal
carcinoma. Cell Rep. 15:857–865. 2016. View Article : Google Scholar : PubMed/NCBI
|
38
|
Seshagiri S, Stawiski EW, Durinck S,
Modrusan Z, Storm EE, Conboy CB, Chaudhuri S, Guan Y, Janakiraman
V, Jaiswal BS, et al: Recurrent R-spondin fusions in colon cancer.
Nature. 488:660–664. 2012. View Article : Google Scholar : PubMed/NCBI
|
39
|
Liu Y, Sun J and Zhao M: ONGene: A
literature-based database for human oncogenes. J Genet Genomics.
44:119–121. 2017. View Article : Google Scholar : PubMed/NCBI
|
40
|
Zhao M, Sun J and Zhao Z: TSGene: A web
resource for tumor suppressor genes. Nucleic Acids Res.
41((Database Issue)): D970–D976. 2013. View Article : Google Scholar : PubMed/NCBI
|
41
|
Hu P, Huang Q, Li Z, Wu X, Ouyang Q, Chen
J and Cao Y: Silencing MAP3K1 expression through RNA interference
enhances paclitaxel-induced cell cycle arrest in human breast
cancer cells. Mol Biol Rep. 41:19–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
42
|
Hirano T, Shino Y, Saito T, Komoda F,
Okutomi Y, Takeda A, Ishihara T, Yamaguchi T, Saisho H and
Shirasawa H: Dominant negative MEKK1 inhibits survival of
pancreatic cancer cells. Oncogene. 21:5923–5928. 2002. View Article : Google Scholar : PubMed/NCBI
|
43
|
Antonucci L, Di Magno L, D'Amico D, Manni
S, Serrao SM, Di Pastena F, Bordone R, Yurtsever ZN, Caimano M,
Petroni M, et al: Mitogen-activated kinase kinase kinase 1 inhibits
hedgehog signaling and medulloblastoma growth through GLI1
phosphorylation. Int J Oncol. 54:505–514. 2019.PubMed/NCBI
|
44
|
Su F, Li H, Yan C, Jia B, Zhang Y and Chen
X: Depleting MEKK1 expression inhibits the ability of invasion and
migration of human pancreatic cancer cells. J Cancer Res Clin
Oncol. 135:1655–1663. 2009. View Article : Google Scholar : PubMed/NCBI
|
45
|
Turkington RC, Longley DB, Allen WL,
Stevenson L, McLaughlin K, Dunne PD, Blayney JK, Salto-Tellez M,
Van Schaeybroeck S and Johnston PG: Fibroblast growth factor
receptor 4 (FGFR4): A targetable regulator of drug resistance in
colorectal cancer. Cell Death Dis. 5:e10462014. View Article : Google Scholar : PubMed/NCBI
|
46
|
Ahmed MA, Selzer E, Dörr W, Jomrich G,
Harpain F, Silberhumer GR, Müllauer L, Holzmann K, Grasl-Kraupp B,
Grusch M, et al: Fibroblast growth factor receptor 4 induced
resistance to radiation therapy in colorectal cancer. Oncotarget.
7:69976–69990. 2016. View Article : Google Scholar : PubMed/NCBI
|
47
|
Heldin CH and Lennartsson J: Structural
and functional properties of platelet-derived growth factor and
stem cell factor receptors. Cold Spring Harb Perspect Biol.
5:a0091002013. View Article : Google Scholar : PubMed/NCBI
|
48
|
Fujino S, Miyoshi N, Ohue M, Takahashi Y,
Yasui M, Hata T, Matsuda C, Mizushima T, Doki Y and Mori M:
Platelet-derived growth factor receptor-β gene expression relates
to recurrence in colorectal cancer. Oncol Rep. 39:2178–2184.
2018.PubMed/NCBI
|
49
|
Mezheyeuski A, Bradic Lindh M, Guren TK,
Dragomir A, Pfeiffer P, Kure EH, Ikdahl T, Skovlund E, Corvigno S,
et al: Survival-associated heterogeneity of marker-defined
perivascular cells in colorectal cancer. Oncotarget. 7:41948–41958.
2016. View Article : Google Scholar : PubMed/NCBI
|
50
|
Schimanski C, Wehler T, Galle P, Gockel I
and Moehler M: PDGFR-α/β expression correlates with the metastatic
behavior of human colorectal cancer-A rationale for a molecular
targeting strategy? J Clin Oncol. 26:220192008. View Article : Google Scholar
|